5-129905250-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_175856.5(CHSY3):​c.421G>A​(p.Ala141Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000488 in 1,455,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

CHSY3
NM_175856.5 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.05

Publications

0 publications found
Variant links:
Genes affected
CHSY3 (HGNC:24293): (chondroitin sulfate synthase 3) CSS3 is a glycosyltransferase that has both glucuronyltransferase and N-acetylgalactosaminyltransferase activities (Yada et al., 2003 [PubMed 12907687]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17986435).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHSY3NM_175856.5 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 3 ENST00000305031.5 NP_787052.3 Q70JA7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHSY3ENST00000305031.5 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 3 1 NM_175856.5 ENSP00000302629.4 Q70JA7

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152126
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000104
AC:
7
AN:
67202
AF XY:
0.000109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000156
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000491
AC:
64
AN:
1303624
Hom.:
0
Cov.:
31
AF XY:
0.0000439
AC XY:
28
AN XY:
638312
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27314
American (AMR)
AF:
0.000153
AC:
4
AN:
26206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20234
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33248
South Asian (SAS)
AF:
0.00
AC:
0
AN:
67796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31218
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4410
European-Non Finnish (NFE)
AF:
0.0000529
AC:
55
AN:
1038850
Other (OTH)
AF:
0.0000920
AC:
5
AN:
54348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152126
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000718

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 26, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.421G>A (p.A141T) alteration is located in exon 1 (coding exon 1) of the CHSY3 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the alanine (A) at amino acid position 141 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
T
Eigen
Benign
0.076
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.58
T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
2.1
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.11
Sift
Benign
0.41
T
Sift4G
Benign
0.19
T
Polyphen
0.90
P
Vest4
0.19
MutPred
0.24
Gain of phosphorylation at A141 (P = 0.0129);
MVP
0.72
MPC
1.1
ClinPred
0.10
T
GERP RS
4.1
Varity_R
0.16
gMVP
0.26
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1012958799; hg19: chr5-129240943; API